EUVIMEDEUVIMED entdecken
Open Access

THC Vapor Inhalation Attenuates Hyperalgesia in Rats Using a Chronic Inflammatory Pain Model

Leslie K Kelley, Savannah H M Lightfoot, Matthew N Hill, Jason W Middleton, Nicholas W Gilpin

The Journal of Pain · 2024

DOI: 10.1016/j.jpain.2024.104649 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pain, 2024. Verfasst von Leslie K Kelley und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; Alcohol and Drug of Abuse Center of Excellence, …. Hauptthemen laut MEDLINE: Hyperalgesia, Dronabinol, Rats, Wistar, Chronic Pain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NIAAA NIH HHS, NIAAA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Humans use cannabinoid drugs to alleviate pain. As cannabis and cannabinoids are legalized in the United States for medicinal and recreational use, it has become critical to determine the potential utilities and harms of cannabinoid drugs in individuals living with chronic pain. Here, we tested the effects of repeated ∆9-tetrahydrocannabinol (THC) vapor inhalation on thermal nociception and mechanical sensitivity, in adult male and female Wistar rats using a chronic inflammatory pain model (ie, treated with complete Freund's adjuvant [CFA]). We report that repeated THC vapor inhalation rescues thermal hyperalgesia in males and females treated with CFA and also reduces mechanical hypersensitivity in CFA males but not females. Many of the antihyperalgesic effects of chronic THC vapor were still observable 24 hours after cessation of the last THC exposure. We also report plasma levels of THC and its major metabolites, some of which are cannabinoid type-1 receptor agonists, after the first and tenth days of THC vapor inhalation. Finally, we report that systemic administration of the cannabinoid type-1 receptor inverse agonist AM251 (1 mg/kg, I.P.) blocks the antihyperalgesic effects of THC vapor in males and females. These data provide a foundation for future work that will explore the cells and circuits underlying the antihyperalgesic effects of THC vapor inhalation in individuals with chronic inflammatory pain. PERSPECTIVE: Cannabinoids are thought to have potential utility in the treatment of chronic pain, but few animal studies have tested the effects of chronic THC or cannabis in animal models of chronic pain. We tested the effects of repeated THC vapor inhalation on chronic pain-related outcomes in male and female animals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperalgesiaDronabinolRats, WistarChronic PainDisease Models, AnimalInflammationAnimalsFemaleMaleRatsAdministration, InhalationPiperidinesPyrazolesFreund's Adjuvant

Stichwörter der Autor:innen

cannabinoid type-1 receptorchronic painsex differencesvapor inhalation∆(9)-Tetrahydrocannabinol

Substanzen

DronabinolAM 251PiperidinesPyrazolesFreund's Adjuvant

Autor:innen und Institutionen

  • Department of Physiology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; Alcohol and Drug of Abuse Center of Excellence, LSUHSC, New Orleans, Louisiana.
  • Departments of Cell Biology and Anatomy and Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
  • Alcohol and Drug of Abuse Center of Excellence, LSUHSC, New Orleans, Louisiana; Neuroscience Center of Excellence, Louisiana State University Health Science Center, New Orleans, Louisiana; Southeast Louisiana VA Healthc…
  • Department of Physiology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; Alcohol and Drug of Abuse Center of Excellence, LSUHSC, New Orleans, Louisiana; Neuroscience Center of Excellence, Lou…

Förderung

  • BLRD VA
  • NIAAA NIH HHS
  • NIAAA
  • US Department of Veterans Affairs
  • Biomedical Laboratory Research and Development, VA Office of Research and Development
  • National Institutes of Health

Zitieren

APA

Kelley, L. K., Lightfoot, S. H. M., Hill, M. N., Middleton, J. W., & Gilpin, N. W. (2024). THC Vapor Inhalation Attenuates Hyperalgesia in Rats Using a Chronic Inflammatory Pain Model. The Journal of Pain. https://doi.org/10.1016/j.jpain.2024.104649

Vancouver

Kelley LK, Lightfoot SHM, Hill MN, Middleton JW, Gilpin NW. THC Vapor Inhalation Attenuates Hyperalgesia in Rats Using a Chronic Inflammatory Pain Model. The Journal of Pain. 2024. doi:10.1016/j.jpain.2024.104649

BibTeX
@article{Kelley2024,
  author = {Kelley, Leslie K and Lightfoot, Savannah H M and Hill, Matthew N and Middleton, Jason W and Gilpin, Nicholas W},
  title = {THC Vapor Inhalation Attenuates Hyperalgesia in Rats Using a Chronic Inflammatory Pain Model},
  journal = {The Journal of Pain},
  year = {2024},
  doi = {10.1016/j.jpain.2024.104649}
}
Kostenlos starten →